For investors navigating the volatile waters of healthcare stocks, agilon health, inc. (NYSE: AGL) presents a tantalizing opportunity. With a projected potential upside of 58.63%, this healthcare provider might pique..
Opko Health, Inc. (NASDAQ: OPK), a Miami-based healthcare company, is making waves in the diagnostics and research industry. With a market capitalization of $913.56 million, Opko Health has captured investor..
Investors eyeing opportunities in the healthcare sector may want to take a closer look at Organon & Co. (NYSE: OGN). With a market cap of $1.65 billion, this U.S.-based pharmaceutical..
Investors looking at the healthcare sector, particularly the medical devices industry, might find Integra LifeSciences Holdings Corporation (NASDAQ: IART) an intriguing prospect. Despite facing some headwinds, significant potential upside is..
Investors seeking opportunities in the healthcare sector may want to keep a close eye on Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX). With a market capitalization of $3.76 billion, this global biopharmaceutical..
Investors are keenly watching Teladoc Health, Inc. (NYSE: TDOC) as the company sits at a pivotal point in the evolution of virtual healthcare services. With a market capitalization of $961.56..
Investors eyeing the healthcare sector’s biotechnology niche might find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) a promising candidate, especially given its substantial potential upside. With a current market capitalization of $3.65..
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands at the intersection of healthcare innovation and investment opportunity. As a prominent player in the medical devices industry, Tandem specializes in advanced insulin..
Evotec SE (EVO), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its focus on a wide array of therapeutic areas. Headquartered in..
Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in medical devices, has recently caught the attention of investors with a notable potential upside of approximately 28.06%...
Pulse Biosciences, Inc (NASDAQ: PLSE) is a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.48 billion, this Miami-based..
Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to treating severe inflammatory and autoimmune diseases. Based..
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is capturing the attention of investors with a compelling potential upside of 36.97%, making it a noteworthy consideration in the biotechnology sector. With a current..
For investors keen on the healthcare sector, Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity. As a key player in the medical care facilities industry, Aveanna is making..
NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the diagnostics and research industry, is making waves in the investment community with its recent market performance. With a market capitalization of..
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, offers intriguing opportunities for investors seeking exposure to innovative healthcare solutions. With a market capitalization of $2.41 billion,..
Haemonetics Corporation (NYSE: HAE), a leading player in the healthcare sector specializing in medical devices, presents an intriguing yet complex investment opportunity. Based in Boston, Massachusetts, the company is renowned..
Alphatec Holdings, Inc. (NYSE: ATEC), a key player in the medical devices industry, has captured the attention of investors with a remarkable potential upside of 92.92%. Specializing in innovative spinal..
Investors seeking opportunities in the healthcare sector may want to turn their attention to MiMedx Group, Inc (MDXG), a promising player in the biotechnology industry. With a market capitalization of..
Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its innovative approach to tackling neurodegenerative and lysosomal storage diseases. With a market capitalization of $3.26 billion,..
